Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 30(8): 971-9, Aug. 1997. graf
Artigo em Inglês | LILACS | ID: lil-197254

RESUMO

The effect of acute (120 mg/kg) and chronic (25 mg/kg, twice a day, for 4 days) intraperitonial injection of the nitric oxide (NO) synthase (NOS) inhibitor N(G)-nitro-L-arginine (L-NOARG) was evaluated on seizure induction by sound drugs such as pilocarpine and pentylenetetrazole (PTZ) and by stimulation of audiogenic seizure-resistant (R) and audiogenic seizure-susceptible (S) rats. Seizures were elicited by a subconvulsant dose of pilocarpine (100 mg/kg) only after NOS inhibition. NOS inhibition also simultaneously potentiated the severity of PTZ-induced limbic seizures (60 mg/kg) and protected against PTZ-induced tonic seizures (80 mg/kg). The audiogenic seizure susceptibility of S or R rats did not change after similar treatments. In conclusion, proconvulsant effects of NOS inhibition are suggested to occur in the pilocarpine model and in the limbic componentes of PTZ-induced seizures, while an anticonvulsant role is suggested for the tonic seizures induced by higher doses of PTZ, revealing inhibitor-specific interations with convulsant dose and also confirming the hypothesis that the effects of NOS inhibitors vary with the model of seizure.


Assuntos
Animais , Ratos , Masculino , Anticonvulsivantes/farmacologia , Convulsivantes/farmacologia , Modelos Animais de Doenças , Epilepsia/tratamento farmacológico , Óxido Nítrico , Óxido Nítrico Sintase , Ratos Sprague-Dawley , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA